Cogstate Ltd - Asset Resilience Ratio
Cogstate Ltd (CGS) has an Asset Resilience Ratio of 54.90% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CGS net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2025)
This chart shows how Cogstate Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CGS total asset value.
Liquid Assets Composition Over Time
This chart breaks down Cogstate Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read CGS total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$35.56 Million | 54.9% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$35.56 Million | 54.90% |
Asset Resilience Insights
- Very High Liquidity: Cogstate Ltd maintains exceptional liquid asset reserves at 54.90% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Cogstate Ltd Industry Peers by Asset Resilience Ratio
Compare Cogstate Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Singular Health Group Ltd
AU:SHG |
Health Information Services | 66.96% |
|
Intrasense
PA:ALINS |
Health Information Services | 15.68% |
|
Medadvisor Ltd
AU:MDR |
Health Information Services | 12.37% |
|
HITIQ Ltd
AU:HIQ |
Health Information Services | 30.25% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 32.70% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
Annual Asset Resilience Ratio for Cogstate Ltd (2004–2025)
The table below shows the annual Asset Resilience Ratio data for Cogstate Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 35.80% | AU$23.19 Million ≈ $16.41 Million |
AU$64.77 Million ≈ $45.83 Million |
+11.27pp |
| 2024-06-30 | 24.53% | AU$14.19 Million ≈ $10.04 Million |
AU$57.84 Million ≈ $40.92 Million |
-37.66pp |
| 2023-06-30 | 62.20% | AU$50.52 Million ≈ $35.74 Million |
AU$81.22 Million ≈ $57.47 Million |
+9.67pp |
| 2022-06-30 | 52.53% | AU$44.65 Million ≈ $31.59 Million |
AU$84.99 Million ≈ $60.14 Million |
+18.43pp |
| 2021-06-30 | 34.10% | AU$23.34 Million ≈ $16.52 Million |
AU$68.44 Million ≈ $48.43 Million |
+11.22pp |
| 2020-06-30 | 22.89% | AU$10.61 Million ≈ $7.51 Million |
AU$46.36 Million ≈ $32.80 Million |
+13.51pp |
| 2019-06-30 | 9.37% | AU$2.57 Million ≈ $1.82 Million |
AU$27.42 Million ≈ $19.40 Million |
-6.52pp |
| 2018-06-30 | 15.89% | AU$4.04 Million ≈ $2.86 Million |
AU$25.43 Million ≈ $18.00 Million |
+3.62pp |
| 2017-06-30 | 12.28% | AU$2.68 Million ≈ $1.90 Million |
AU$21.87 Million ≈ $15.47 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$19.63 Million ≈ $13.89 Million |
-- |
| 2005-06-30 | 52.63% | AU$1.76 Million ≈ $1.25 Million |
AU$3.35 Million ≈ $2.37 Million |
-30.98pp |
| 2004-06-30 | 83.61% | AU$3.67 Million ≈ $2.60 Million |
AU$4.39 Million ≈ $3.11 Million |
-- |
About Cogstate Ltd
Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, includ… Read more